INS and Hyperglycemia: The incidence of PTDM using these new guidelines is as yet unknown, but the increasing frequency of obesity, the significant impact of current immunosuppression regimens on insulin secretion and action, and the greater scrutiny of glucose control in all hospitalizations have led to the recognition that significant hyperglycemia is very common in the immediate post-transplant hospitalization.